rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2011-8-26
|
pubmed:abstractText |
The phosphatidylinositol 3-kinase (PI3K)/protein kinase B(AKT)/mammalian target of rapamycin (mTOR) signaling pathway is aberrantly activated in many types of cancer, including breast cancer. It is recognized that breast cancer cells develop resistance to a variety of standard therapies through the activation of this pathway. We hypothesized that targeting this signaling by the mTOR inhibitor RAD001 may potentiate the cytotoxicity of a conventional chemotherapeutic drug, carboplatin, and enhance the treatment efficacy for breast cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1791-7530
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2713-22
|
pubmed:meshHeading |
pubmed-meshheading:21868512-Antineoplastic Agents,
pubmed-meshheading:21868512-Apoptosis,
pubmed-meshheading:21868512-Blotting, Western,
pubmed-meshheading:21868512-Breast Neoplasms,
pubmed-meshheading:21868512-Cell Cycle,
pubmed-meshheading:21868512-Cell Line, Tumor,
pubmed-meshheading:21868512-Drug Synergism,
pubmed-meshheading:21868512-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21868512-Female,
pubmed-meshheading:21868512-Flow Cytometry,
pubmed-meshheading:21868512-Genes, p53,
pubmed-meshheading:21868512-Humans,
pubmed-meshheading:21868512-Membrane Potentials,
pubmed-meshheading:21868512-Sirolimus,
pubmed-meshheading:21868512-TOR Serine-Threonine Kinases
|
pubmed:year |
2011
|
pubmed:articleTitle |
The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.
|
pubmed:affiliation |
Division of Oncology and Hematology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. jan.eucker@charite.de and hongyu.liu@charite.de.
|
pubmed:publicationType |
Journal Article
|